| 英文名称 | CAS号 | 中文名 | 中文别名 | 分子式 | 分子量 | EINECS号 |
|---|---|---|---|---|---|---|
|
Torsemide Impurity A
|
72810-61-8 |
托拉塞米杂质A
|
托拉塞米EP杂质A;托拉塞米相关物质E;托拉塞米杂质A;托米塞特杂质A
|
C13H11N3O3S |
289.31 | |
|
Torsemide Impurity E
|
72810-57-2 |
缬沙坦苄酯
|
[[4-[(3-甲基苯基)氨基]-3-吡啶基]磺酰基]氨基甲酸乙酯;托拉塞米EP杂质E
|
C15H17N3O5S |
351.37758 | |
|
TorseMide-d7
|
1189375-06-1 |
托拉塞米-D7
|
托拉塞米-D7
|
C16H20N4O3S |
348.42 | |
|
Topiramate EP Impurity B
|
876403-98-4 |
TOPIRAMATE
|
Topiramate EP Impurity B;Topiramate Impurity 2 (Topiramate EP Impurity B)
|
|||
|
Tolterodine Impurity 9
|
1189501-90-3 |
托特罗定杂质
|
|
C16H19NO |
241.32816 | |
|
Tolterodine EP Impurity E
|
480432-14-2 |
托特罗定单异丙基酯
|
托特罗定单异丙基酯;托特罗定单异丙基类似物
|
C19H25NO |
283.4079 | |
|
Tofacitinib Impurity 61
|
1821769-41-8 |
托法替尼杂质3
|
TOFACITINIB-3;托法替尼杂质03;(3S,4R)-(1-苄基-4-甲基哌啶-3-基)甲胺盐酸盐(M5非对映B);托法替尼杂质M4-SR
|
C14H24Cl2N2 |
291.3 | |
|
Tofacitinib Impurity 21
|
1640972-35-5 |
托法替尼杂质
|
TOFACITINIB-21;托法替尼杂质 6;M8加氢杂质;N-甲基-N-((3S,4R)-4-甲基哌啶-3-基)-7H-吡咯并[2,3-D]嘧啶-4-胺 (M7非对映异构体B);托法替尼杂质39;托法替尼相关化合物21
|
C16H22N6O |
314.38548 | |
|
Tofacitinib Impurity 9
|
1616761-00-2 |
托法替尼杂质
|
3-((3R,4R)-3-((2-氯-7H-吡咯并[2,3-D]吡啶-4-基)(甲氨基)-4-甲哌啶-1-基)-3-氧杂丙腈;TOFACITINIB-20;M8带氯杂质;3-((3R,4R)-3-((2-氯-7H--吡咯并[2,3-D]嘧啶-4-基)(甲基)氨基)-4-甲基哌啶-1-基)-3-氧丙腈;托法替尼杂质YT;托伐替尼杂质8;托法替尼杂质PF-05087352;托法替尼杂质 8
|
C16H19ClN6O |
346.81466 | |
|
Tofacitinib Impurity U
|
1616760-97-4 |
托法替尼杂质 2
|
托法替尼杂质 2;托法替尼杂质31;2-氯-N-甲基-N-((3R,4R)-4-甲基哌啶-3-基)-7H-吡咯并[2,3-D]嘧啶-4-胺;托法替布杂质2;TOFACITINIB-30;托法替尼M26;M7带氯的中间态
|
|||
|
N-Methylbenzylamine
|
103-67-3 |
N-甲基苄胺
|
N-甲基苯甲胺;苄基甲胺;甲替苄胺;N-甲基苄胺;甲基苄胺;N-苯基马来甲胺;N-苯甲基甲胺;N-苄基甲胺
|
C8H11N |
121.18 | 203-133-4 |
|
BENZYL ETHYL ETHER
|
539-30-0 |
苄基乙醚
|
(乙氧基甲基(苯;苄基乙醚;苄基乙氧基;苄乙醚;乙基苄基醚;苄基乙基醚 10G;酵母粉葡萄糖氯霉素琼脂培养基:YEAST EXTRACT GLUCOSE CHLORAMPHENICOL AGAR;苯甲醇杂质10
|
C9H12O |
136.19 | 208-714-6 |
|
Tofacitinib Impurity 134
|
1092578-44-3 |
托法替尼杂质2
|
Tofacitinib Impurity 134
|
|||
|
Tofacitinib Impurity 133
|
2056104-91-5 |
托法替尼杂质19
|
Tofacitinib Impurity 133
|
|||
|
Tofacitinib Impurity 130
|
1092578-45-4 |
托法替尼-IMZ1
|
N-((3R,4S)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine;Tofacitinib Impurity 130
|
|||
|
Tofacitinib Impurity 83
|
1640971-51-2 |
托法替尼杂质
|
Tofatinib impurity;3-((3R,4R)-4-methyl-3-(methyl(6-oxo-6,7-dihydro-5H-pyrrolo[2,3-d] pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile
|
|||
|
Tofacitinib Impurity 78
|
1206875-41-3 |
托法替尼中间体VI
|
Methyl (1-benzyl-4-Methylpiperidin-3-yl)carbaMate;methyl 1-benzyl-4-methylpiperidin-3-ylcarbamate(Cis);Tofacitinib Related Impurity 5;Tofacitinib Impurity 78
|
|||
|
Tofacitinib Impurity 77
|
1204176-45-3 |
托法替尼中间体V
|
托法替尼中间体V;托法替尼相关杂质4;托法替尼杂质77
|
C8H16N2O2 |
172.22484 | |
|
Tofacitinib Impurity 68
|
1616761-01-3 |
托法替尼杂质29
|
TOFACITINIB-28;托法替尼杂质29
|
C17H23N5O3 |
345.39622 | |
|
Tofacitinib related compound 4
|
1092578-43-2 |
托伐替尼杂质T
|
Tofacitinib impurity 16/2-cyano-N-methyl-N-((3R,4R)-4-methyl-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-3-yl)acetamide;Tofacitinib-22;2-cyano-N-methyl-N-((3R,4R)-4-methyl-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-3-yl)acetamide
|
药智官方微信
药智官方微博
